Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Postoperative Analgesia in Cardiac Surgery
NCT03270514Phase 3Completed
- Start
- Nov 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain. Primary endpoint: Post-operative Pain Intensity at 72 hours. Started Nov 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03270514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03270514.